NXS 2.63% 19.5¢ next science limited

6 days to go, page-5

  1. 3,750 Posts.
    lightbulb Created with Sketch. 3024
    And again!...in relation to capital and the liquids deal, I would say the company has demonstrated an innovative approach to capital needs and established good credentials in risk management. To the extent capital is needed for Crux they have engaged about the best partner in the world and retained flexibility to either fund or farm down their interests in pursuit of development. I'm a happy camper with NXS and believe the main reason for recent weakness has been the swapping by some investors towards the Basker Manta partners as it reaches production.

    regards
    DF
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.